Reviewing Peer Review

Reviewing Peer Review In response to the Closing Bell article in Jan. 27, 2003,1 I often think that the peer review system being blinded only one way (i.e., against the submitter but not the reviewer) is flawed and should be made transparent. Unblinding peer review may make the scientific process more adversarial, since rejections can be taken personally against a reviewer. Another potential disadvantage would be that collaborations between related labs might become harder to come by. Howev

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In response to the Closing Bell article in Jan. 27, 2003,1 I often think that the peer review system being blinded only one way (i.e., against the submitter but not the reviewer) is flawed and should be made transparent. Unblinding peer review may make the scientific process more adversarial, since rejections can be taken personally against a reviewer. Another potential disadvantage would be that collaborations between related labs might become harder to come by. However, the advantages are that this may weed out fraudulent science and criminal activity sooner, and reviewers/ editors are compelled to make more honest, fair, and knowledgeable assessments of submitted manuscripts. If this is an unreasonable suggestion, then perhaps peer review should be blinded both ways to be fair to everyone.

Romulo de Castro Jr., PhD
The Burnham Institute
La Jolla, Calif.
jongdc@burnham.org

***

I wonder if we should consider fraud a not infrequent case of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies